Ross Porter

University of Edinburgh

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Stephanie Craig

The Queen's University Belfast

UNITED KINGDOM

View details

Peter Bankhead

Reader

University of Edinburgh

UNITED KINGDOM

View details

Mark Arends

Professor of Pathology, Head of Division

University of Edinburgh

UNITED KINGDOM

View details

Daniel Paul Brice

The University of Manchester

UNITED KINGDOM

View details

Weini Huang

Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

View details

Mairi McLean

University of Aberdeen

UNITED KINGDOM

View details

Manuel Salto-Tellez

Professor of Integrated Pathology

Institute of Cancer Research

UNITED KINGDOM

View details

Heather M Wilson

University of Aberdeen

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ross Porter

Research Interests

Explore related searches

Contact this professor

Articles (10)

Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an ‘Immune Cold’ Phenotype Associated with Poor Survival

QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray

Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model

Clonal Transitions and Phenotypic Evolution in Barrett's Esophagus

Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstruction

Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate

Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines

Lessons from recent medical history: an obsolete anti-reflux device in an older patient with variable gastrointestinal symptoms

Current concepts in tumour-derived organoids

Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit

Collaborators (8)

Stephanie Craig

Peter Bankhead

Mark Arends

Daniel Paul Brice

Weini Huang

Mairi McLean

Manuel Salto-Tellez

Heather M Wilson

Make your next move.